Clinical Drug Experience Knowledgebase

Asthma (Phase 3)

Blood Coagulation Disorders (Phase 1)

Carcinoma, Squamous Cell (Phase 4)

Communicable Diseases (Phase 3)

Diarrhea (Phase 3)

Dyspnea (Phase 1)

Fatty Liver (Phase 4)

Glioblastoma (Phase 2)

Hemostatic Disorders (Phase 1)

Hypertension (Phase 4)

Infections (Phase 3)

Influenza, Human (Phase 3)

Kidney Diseases (Phase 2)

Liver Diseases (Phase 4)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Melanoma (Phase 4)

Multiple Myeloma (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 4)

Obesity (Phase 4)

Prostatic Neoplasms (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Renal Insufficiency (Phase 2)

Renal Insufficiency, Chronic (Phase 2)

Respiratory Tract Infections (Phase 3)